Answers are grounded in this paper and cite their sources.
Systematic evaluation demonstrates efficacy of bacteriophage therapy against antibiotic-resistant bacteria, highlighting its potential as a safe alternative.
Antibiotic resistance in pathogens like E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa poses a major threat to global health, with limited treatment options. This study systematically evaluated the efficacy of bacteriophage therapy in vitro and in vivo against multidrug-resistant strains. Phage treatment led to significant bacterial reduction (up to 4.5 log₁₀ CFU/mL) and improved survival rates in mice (up to 85%). Synergistic effects with antibiotics and preservation of gut microbiota were observed without adverse reactions. These findings highlight phage therapy as a promising, targeted, and safe alternative for managing resistant infections.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: